Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
To satisfy regulators before they merge, Pfizer and Wyeth have agreed to sell certain Wyeth animal-health assets to Boehringer Ingelheim. The German company will acquire vaccines and some drug products, primarily in the U.S. and Canada, along with research and manufacturing facilities located in Fort Dodge, Iowa. Boehringer may also gain certain other assets in Australia, South Africa, and the European Union, pending regulatory approvals. The companies did not disclose any financial details. Separately, Sanofi-Aventis has completed its $4 billion purchase of Merck & Co.’s 50% interest in their animal-health joint venture, Merial.
This article has been sent to the following recipient: